Dumon, Mae Antonette D.

HRN: 08-19-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2022
CEFUROXIME 750MG (VIAL)
04/18/2022
04/25/2022
IV
750
Q8H
POST-OP PROPHYLAXIS
04/19/2022
CEFUROXIME 500MG (TAB)
04/20/2022
04/26/2022
PO
500mg
BID X 7 Days
WBC: 18.8; S/p LTCS With IUD Insertion For Oligohydramnios; Overt DM-insulin Requiring (controlled)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: